New Delhi: Drug firm
Morepen Laboratories on Monday reported a 5.05 per cent rise in its
consolidated net profit to Rs 11.02 crore for the quarter ended March
31, 2020.
The company had posted a net profit of Rs 10.49 crore for the corresponding period of the previous financial year, Morepen Laboratories said in a filing to the BSE.
Its consolidated total revenue stood at Rs 208.38 crore for the quarter under consideration, against Rs 219.74 crore a year ago, it added.
For the full financial year 2019-20, its net profit was Rs 33.57 crore. It was Rs 28.84 crore for the previous financial year, Morepen Labs said.
The company had posted a net profit of Rs 10.49 crore for the corresponding period of the previous financial year, Morepen Laboratories said in a filing to the BSE.
Its consolidated total revenue stood at Rs 208.38 crore for the quarter under consideration, against Rs 219.74 crore a year ago, it added.
For the full financial year 2019-20, its net profit was Rs 33.57 crore. It was Rs 28.84 crore for the previous financial year, Morepen Labs said.
Comments
Post a Comment